TSV
J-Codes (HCPCS Level II Drug Codes) - TSV
J-Codes are a standardized pharmaceutical coding system under HCPCS (Healthcare Common Procedure Coding System) Level II, primarily used to identify non-oral medications such as injectable drugs, infusion solutions, inhalation medications, and chemotherapy drugs. Managed by CMS (Centers for Medicare & Medicaid Services), these codes are widely used for insurance claims in healthcare facilities and pharmaceutical management in medical information systems. The format combines the letter 'J' with four digits, accurately conveying drug names, dosages, and administration methods.
HCPCS
medical billing
injectable drugs
drug codes
CMS
insurance claims
healthcare information systems
code slug name description category dosage
J0120 tetracycline-injection Tetracycline Injection Injectable antibiotic tetracycline. Antibiotics up to 250mg
J0150 adenosine-injection Adenosine Injection Injectable adenosine for arrhythmia treatment. Cardiovascular Agents 1mg
J1885 ketorolac-injection Ketorolac Tromethamine Injection Injectable nonsteroidal anti-inflammatory drug (NSAID). Analgesics / Anti-inflammatory 15mg
J2270 morphine-sulfate-injection Morphine Sulfate Injection Injectable opioid analgesic. Opioid Analgesics up to 10mg
J2357 omalizumab-injection Omalizumab Injection Anti-IgE antibody biologic agent. Biologics / Immunosuppressants 5mg
J2919 immune-globulin-injection Immune Globulin Injection Intravenous immune globulin (IVIG) preparation. Blood Products / Immune Globulins 500mg
J3490 unclassified-drugs Unclassified Drugs Generic code for drugs without specific assigned J-codes. Other varies
J9190 fluorouracil-injection Fluorouracil Injection Injectable antineoplastic agent (antimetabolite). Antineoplastic / Chemotherapy Agents 500mg
J9035 bevacizumab-injection Bevacizumab Injection Anti-VEGF antibody antineoplastic agent. Antineoplastic / Targeted Therapy 10mg
J9312 rituximab-injection Rituximab Injection Anti-CD20 antibody biologic agent. Antineoplastic / Immunosuppressants 10mg